Literature DB >> 6110865

Cimetidine reduction of tumour formation in mice.

R R Gifford, R M Ferguson, B V Voss.   

Abstract

Cimetidine, a histamine type-2 receptor antagonist, had a protective effect in mice challenged with cells from two different syngeneic tumours. The results are a further indication of cimetidine's potential as an immunostimulator.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6110865     DOI： 10.1016/s0140-6736(81)91555-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  25 in total

1.  The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.

Authors:  J Drews
Journal:  Infection       Date:  1985       Impact factor: 3.553

2.  Pathophysiological significance of the distribution of histamine receptor sub-types: a proposed dual role for histamine in inflammation and type I hypersensitivity reactions.

Authors:  P F Mannaioni; R Fantozzi; E Giannella; E Masini
Journal:  Agents Actions       Date:  1988-06

3.  Immunostimulation. Clinical and experimental perspectives.

Authors:  J Drews
Journal:  Klin Wochenschr       Date:  1984-03-15

4.  The role of histamine antagonists on the development of experimental cancer in the rat.

Authors:  J Nee; N O'Higgins; D H Osborne; S Purdy
Journal:  Ir J Med Sci       Date:  1984-10       Impact factor: 1.568

5.  The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.

Authors:  J Drews
Journal:  Infection       Date:  1984 Mar-Apr       Impact factor: 3.553

6.  The effect of cimetidine on antibody synthesis in vitro and in vivo.

Authors:  A M Badger; A E Brown; G Poste
Journal:  Immunology       Date:  1983-01       Impact factor: 7.397

7.  Inefficacy of cimetidine in condylomata acuminata.

Authors:  F H Rampen; J J van Everdingen
Journal:  Br J Vener Dis       Date:  1982-08

8.  Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidine.

Authors:  S A Watson; L J Wilkinson; J F Robertson; J D Hardcastle
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

9.  Effects of histamine type-2 receptor antagonists on indomethacin and IL-2 immunotherapy of metastasis.

Authors:  M N Saarloos; N K Khoo; P K Lala
Journal:  Clin Exp Metastasis       Date:  1993-05       Impact factor: 5.150

10.  Immunological studies in patients with alopecia receiving dinitrochlorobenzene and cimetidine therapy.

Authors:  K Thestrup-Pedersen; S Bisballe; J R Jensen; H Zachariae
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.